Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nikolaus

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Gut|June 9, 1998
Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammationS Nikolaus, J Bauditz, P Gionchetti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
Imaging of striatal dopamine D(2) receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with (18)F-(N-methyl)benperidolS Nikolaus, R Larisch, M Beu, et al.
Gut|February 15, 2001
Increased expression of IL-16 in inflammatory bowel diseaseD Seegert, P Rosenstiel, H Pfahler, et al.
Lancet (London, England)|June 3, 1995
Tumour necrosis factor inhibition by oxpentifylline and intestinal inflammation in Crohn's diseaseJ Bauditz, Y Rückert, A Raedler, et al.
Inflammatory Bowel Diseases|January 4, 2013
IL-4 Signaling Mechanisms in Inflammatory Bowel Disease Mononuclear PhagocytesY Rückert, U Schindler, T Heinig, et al.
Gut|May 13, 2009
A possible link between TIMP-1 induction and response to infliximabS Derer, G H Waetzig, D Seegert, et al.
Der Internist|January 15, 2003
[Genetics and the environment. Has the picture become clearer?]S Schreiber, J Hampe, J Grebe, et al.
Clinical and Experimental Rheumatology|February 14, 2012
Expert evaluations of fatigue questionnaires used in rheumatoid arthritis: a Delphi study among patients, nurses and rheumatologists in the NetherlandsS Nikolaus, C Bode, E Taal, et al.
Lancet (London, England)|November 18, 2000
Mechanisms in failure of infliximab for Crohn's diseaseS Nikolaus, A Raedler, T Kühbacker, et al.
International Journal of Immunogenetics|August 9, 2006
The FCGR2A--Arg131 variant is no major mortality factor in the elderly--evidence from a German centenarian studyB K Flesch, S Nikolaus, N E El Mokhtari, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Gut|June 9, 1998
Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammationS Nikolaus, J Bauditz, P Gionchetti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
Imaging of striatal dopamine D(2) receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with (18)F-(N-methyl)benperidolS Nikolaus, R Larisch, M Beu, et al.
Gut|February 15, 2001
Increased expression of IL-16 in inflammatory bowel diseaseD Seegert, P Rosenstiel, H Pfahler, et al.
Lancet (London, England)|June 3, 1995
Tumour necrosis factor inhibition by oxpentifylline and intestinal inflammation in Crohn's diseaseJ Bauditz, Y Rückert, A Raedler, et al.
Inflammatory Bowel Diseases|January 4, 2013
IL-4 Signaling Mechanisms in Inflammatory Bowel Disease Mononuclear PhagocytesY Rückert, U Schindler, T Heinig, et al.
Gut|May 13, 2009
A possible link between TIMP-1 induction and response to infliximabS Derer, G H Waetzig, D Seegert, et al.
Der Internist|January 15, 2003
[Genetics and the environment. Has the picture become clearer?]S Schreiber, J Hampe, J Grebe, et al.
Clinical and Experimental Rheumatology|February 14, 2012
Expert evaluations of fatigue questionnaires used in rheumatoid arthritis: a Delphi study among patients, nurses and rheumatologists in the NetherlandsS Nikolaus, C Bode, E Taal, et al.
Lancet (London, England)|November 18, 2000
Mechanisms in failure of infliximab for Crohn's diseaseS Nikolaus, A Raedler, T Kühbacker, et al.
International Journal of Immunogenetics|August 9, 2006
The FCGR2A--Arg131 variant is no major mortality factor in the elderly--evidence from a German centenarian studyB K Flesch, S Nikolaus, N E El Mokhtari, et al.
Pageof 6